Resources

  • References


    Dhillon RH, Clark J. ESBLs: a clear and present danger?
    Crit Care Res Pract.
    2012;2012:1-11.


    Doi Y, Adams J, O'Keefe Alexandra, Quereshi Z, Ewan L, Paterson DS. Community-acquired extended spectrum beta-lactamase producers, United States.
    Emerg Infect Dis.
    2007; 13(7): 1121-1123.


    Extended-spectrum beta-lactamases (ESBLs). Public Health England website. Available at:
    http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/ESBLs. Accessed June 19, 2014.


    Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update.
    Clin Microbiol Rev. 2005;18(4):657–686.


    Seigel JD, Rhinehart E, Jackson M. Management of multidrug-resistant organisms in healthcare settings, 2006. Available at:
    http://www.cdc.gov/hicpac/pdf/guidelines/MDROGuideline2006.pdf. Updated December 29, 2009. Accessed June 19, 2014.

  • Resources

    Centers for Disease Control and Prevention

    http://www.cdc.gov

    National Institute of Allergy and Infectious Diseases

    http://www.niaid.nih.gov

  • Canadian Resources

    Public Health Agency of Canada

    http://www.phac-aspc.gc.ca